SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991; 265: 32703274.
  • 2
    Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997; 89: 272275.
  • 3
    Nicolaides KH, Soothill PW, Rodeck CH, Clewell W. Rh disease: intravascular fetal blood transfusion by cordocentesis. Fetal Ther 1986; 1: 185192.
  • 4
    Ryan G, Morrow RJ. Fetal blood transfusion. Clin Perinatol 1994; 21: 573589.
  • 5
    Weiner CP, Wenstrom KD, Sipes SL, Williamson RA. Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol 1991; 165: 10201025.
  • 6
    Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997; 21: 3944.
  • 7
    Schumacher B, Moise KJ, Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996; 88: 137150.
  • 8
    Benacerraf BR, Barss VA, Saltzman DH, Greene MF, Penso CA, Frigoletto FD Jr. Acute fetal distress associated with percutaneous umbilical blood sampling. Am J Obstet Gynecol 1987; 156: 12181220.
  • 9
    Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, Kanhai HH. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192: 171177.
  • 10
    Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992; 79: 390393.
  • 11
    Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342: 914.
  • 12
    Zimmerman R, Carpenter RJ Jr, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002; 109: 746752.
  • 13
    Liley AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol 1961; 82: 13591370.
  • 14
    Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, Kanhai HH, Ohlsson A, Ryan G. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006; 355: 156164.
  • 15
    Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibashan RS, Campbell S. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988; 1: 10731075.
  • 16
    Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2002; 100: 600611.
  • 17
    Poissonnier MH, Picone O, Brossard Y, Lepercq J. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization. Fetal Diagn Ther 2003; 18: 467471.
  • 18
    Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997; 25: 8588.
  • 19
    Ruma MS, Moise KJ Jr, Kim E, Murtha AP, Prutsman WJ, Hassan SS, Lubarsky SL. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007; 196: 138 e16.
  • 20
    Westgren M, Selbing A, Stangenberg M. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation. BMJ 1988; 296: 885886.
  • 21
    Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fetal Diagn Ther 2008; 23: 159163.
  • 22
    Harman CR, Bowman JM, Manning FA, Menticoglou SM. Intrauterine transfusion—intraperitoneal versus intravascular approach: a case–control comparison. Am J Obstet Gynecol 1990; 162: 10531059.
  • 23
    Oepkes D, Adama van Scheltema P. Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia. Semin Fetal Neonatal Med 2007; 12: 432438.
  • 24
    Somerset DA, Moore A, Whittle MJ, Martin W, Kilby MD. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis. Fetal Diagn Ther 2006; 21: 272276.
  • 25
    Ghi T, Brondelli L, Simonazzi G, Valeri B, Santini D, Sandri F, Ancora G, Pilu G. Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions. Ultrasound Obstet Gynecol 2004; 23: 428431.
  • 26
    Hudon L, Moise KJ Jr, Hegemier SE, Hill RM, Moise AA, Smith EO, Carpenter RJ. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol 1998; 179: 858863.
  • 27
    Grab D, Paulus WE, Bommer A, Buck G, Terinde R. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Obstet Gynecol 1999; 93: 165168.
  • 28
    Kempe A, Rosing B, Berg C, Kamil D, Heep A, Gembruch U, Geipel A. First-trimester treatment of fetal anemia secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol 2007; 29: 226228.